Terms: = Lung cancer AND CEACAM5, CEA AND Clinical Outcome
11 results:
1. clinical impact of pleural fluid carcinoembryonic antigen on therapeutic strategy and efficacy in lung adenocarcinoma patients with malignant pleural effusion.
Lee J; Lee DH; Park JE; Lee YH; Choi SH; Seo H; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Korean J Intern Med; 2024 Mar; 39(2):318-326. PubMed ID: 38351680
[TBL] [Abstract] [Full Text] [Related]
2. A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer.
Zhou C; Chen Z; Zhao L; Zhao W; Zhu Y; Liu J; Zhao X
J Clin Lab Anal; 2020 Nov; 34(11):e23505. PubMed ID: 33463758
[TBL] [Abstract] [Full Text] [Related]
3. Survival Prediction and Adjuvant Chemotherapy Based on Tumor Marker for Stage IB lung Adenocarcinoma.
Wang Y; Zheng D; Chen T; Zhang J; Yao F; Chen H
Ann Thorac Surg; 2020 Mar; 109(3):927-937. PubMed ID: 31614135
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot.
Moritz R; Muller M; Korse CM; van den Broek D; Baas P; van den Noort V; Ten Hoeve JJ; van den Heuvel MM; van Rossum HH
Clin Chim Acta; 2018 Dec; 487():6-14. PubMed ID: 30201371
[TBL] [Abstract] [Full Text] [Related]
5. clinical outcome of subcentimeter non-small cell lung cancer after surgical resection: single institution experience of 105 patients.
Jiang W; Pang X; Xi J; Chen X; Wang Q; Qian C; Fan H
J Surg Oncol; 2014 Sep; 110(3):233-8. PubMed ID: 24888753
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic impact of nm23-H1 and PCNA expression in pathologic stage I non-small cell lung cancer.
Liu C; Liu J; Wang X; Mao W; Jiang L; Ni H; Mo M; Wang W
J Surg Oncol; 2011 Aug; 104(2):181-6. PubMed ID: 21495034
[TBL] [Abstract] [Full Text] [Related]
7. Development of a multimarker assay for early detection of ovarian cancer.
Yurkovetsky Z; Skates S; Lomakin A; Nolen B; Pulsipher T; Modugno F; Marks J; Godwin A; Gorelik E; Jacobs I; Menon U; Lu K; Badgwell D; Bast RC; Lokshin AE
J Clin Oncol; 2010 May; 28(13):2159-66. PubMed ID: 20368574
[TBL] [Abstract] [Full Text] [Related]
8. NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity.
Osada T; Clay T; Hobeika A; Lyerly HK; Morse MA
Cancer Immunol Immunother; 2006 Sep; 55(9):1122-31. PubMed ID: 16273350
[TBL] [Abstract] [Full Text] [Related]
9. Gallbladder carcinomas: an immunoprognostic evaluation of P53, Bcl-2, cea and alpha-fetoprotein.
Kanthan R; Radhi JM; Kanthan SC
Can J Gastroenterol; 2000 Mar; 14(3):181-4. PubMed ID: 10758414
[TBL] [Abstract] [Full Text] [Related]
10. Tumor markers and lung cancer: guidelines in a cost-limited medical organization.
Falcone F; Marinelli M; Minguzzi L; Paganelli GM; Turba E; Cavalli A; Rapellino M
Int J Biol Markers; 1996; 11(2):61-6. PubMed ID: 8776605
[TBL] [Abstract] [Full Text] [Related]
11. Metastatic potential of human colorectal carcinomas implanted into nude mice: prediction of clinical outcome in patients operated upon for cure.
Jessup JM; Giavazzi R; Campbell D; Cleary KR; Morikawa K; Hostetter R; Atkinson EN; Fidler IJ
Cancer Res; 1989 Dec; 49(24 Pt 1):6906-10. PubMed ID: 2582433
[TBL] [Abstract] [Full Text] [Related]
